News

C&EN1d
Carbonic Anhydrase Inhibitors. Design of Fluorescent Sulfonamides as Probes of Tumor-Associated Carbonic Anhydrase IX That Inhibit Isozyme IX-Mediated Acidification of Hypoxic ...
Polo Scientifico, Laboratorio di Chimica Bioinorganica, Rm. 188, Università degli Studi di Firenze, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy, Centre of Molecular Medicine, ...
Electrospun polymer fiber mats enable controlled release of antibacterial drugs for wound care
A good drug should cure without harming. A lot depends, however, not so much on the therapeutic substance itself, as on the ...
C&EN9d
Novel Indole-Based Peroxisome Proliferator-Activated Receptor Agonists: Design, SAR, Structural Biology, and Biological Activities
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan, Republic of China, and Department of Chemistry and ...
Morningstar19d
Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole
Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole Saptalis Pharmaceuticals LLC proudly announces the ...
Yahoo Finance19d
Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole
HAUPPAUGE, N.Y., May 20, 2025--(BUSINESS WIRE)--Saptalis Pharmaceuticals LLC proudly announces the launch of LIKMEZ ® (metronidazole) oral suspension, 500 mg/5 mL (100 mg/ mL), an innovative ...
The Bakersfield Californian20d
Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole
Saptalis Pharmaceuticals LLC proudly announces the launch of LIKMEZ ® (metronidazole) oral suspension, 500 mg/5 mL (100 mg/ mL), an innovative liquid formulation developed specifically for ...
urologytimes20d
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
The AMPLIFY trial evaluates 64Cu-SAR-bisPSMA's efficacy in detecting prostate cancer lesions in patients with biochemical recurrence. 64Cu-SAR-bisPSMA has received FDA fast track designation for PET ...
The Lancet24d
The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments
dDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, USA eCollege of Pharmacy, University of Michigan, Ann Arbor, MI, USA ...
IEEE24d
Time-Weighted SAR in Rats for the Estimation of Practical RF Exposure in Reverberation Chambers
Abstract: Herein, we present a new method for the calculation of the specific absorption rate (SAR) of rats (named time-weighted SAR) to practically consider the effect of the ever-changing movements ...
IEEE24d
A Gaussian Process Based Approach for Validation of Multi-Variable Measurement Systems: Application to SAR Measurement Systems
It has been applied to two systems that measure specific absorption rate (SAR) for compliance testing of wireless devices and apply different SAR measurement methods: a probe-scanning system (per ...
Frontiers25d
Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis
Background: Chronic endometritis (CE) has been widely recognized as a potential cause of infertility, however, access to effective treatment is a formidable challenge due to the rudimentary ...